Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas

Nature Genetics

Volumn 46, Issue 2, 2014, Pages 166-170

  Palomero, Teresa ^a,b   Couronné, Lucile ^a   Khiabanian, Hossein ^a   Kim, Mi Yeon ^a   Ambesi Impiombato, Alberto ^a   Perez Garcia, Arianne ^a   Carpenter, Zachary ^a   Abate, Francesco ^a,c   Allegretta, Maddalena ^a   Haydu, J Erika ^a   Jiang, Xiaoyu ^d   Lossos, Izidore S ^d,e   Nicolas, Concha ^f   Balbin, Milagros ^g   Bastard, Christian ^h   Bhagat, Govind ^b   Piris, Miguel A ⁱ   Campo, Elias ^j,k   Bernard, Olivier A ^l,m   Rabadan, Raul ^a   Ferrando, Adolfo A ^a,b   more..

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c POLITECNICO DI TORINO   (Italy)

^d UNIVERSITY OF MIAMI   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^h UNIVERSITÉ DE ROUEN   (France)

ⁱ HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^j HOSPITAL CLÍNIC   (Spain)

^k UNIVERSITY OF BARCELONA   (Spain)

^l INSERM   (France)

^m INSTITUT GUSTAVE ROUSSY   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; DNA; DNA METHYLTRANSFERASE 3A; GUANINE EXCHANGE FACTOR; ISOCITRATE DEHYDROGENASE 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PROTEIN; PROTEIN KINASE FYN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; ATM GENE; B2M GENE; CARCINOGENESIS; CD58 GENE; CONTROLLED STUDY; DNA DAMAGE; DNMT3A GENE; EPIGENETIC REPRESSION; EXOME; FYN GENE; GENE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IDH2 GENE; IMMUNOSURVEILLANCE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; RHOA GENE; RNA SEQUENCE; SIGNAL TRANSDUCTION; TET2 GENE; TET3 GENE; TUMOR ESCAPE; TUMOR SUPPRESSOR GENE;

ANTIGENS, CD58; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BASE SEQUENCE; COMPUTATIONAL BIOLOGY; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; ESCHERICHIA COLI; EXOME; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; ISOCITRATE DEHYDROGENASE; LYMPHOMA, T-CELL, PERIPHERAL; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FYN; RHOA GTP-BINDING PROTEIN; SEQUENCE ANALYSIS, RNA;

EID: 84895829862     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2873     Document Type: Article

References (36)

1. Armitage, J.O. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management. Am. J. Hematol. 87, 511-519 (2012
2. Rüdiger, T. et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): Results from the Non-Hodgkin's Lymphoma Classification Project. Ann. Oncol. 13, 140-149 (2002
3. Schiller, M.R. Coupling receptor tyrosine kinases to Rho GTPases-GEFs what's the link. Cell. Signal. 18, 1834-1843 (2006
4. Bar-Sagi, D. & Hall, A. Ras and Rho GTPases: A family reunion. Cell 103, 227-238 (2000
5. Vega, F.M. & Ridley, A.J. Rho GTPases in cancer cell biology. FEBS Lett. 582, 2093-2101 (2008
6. Hanna, S. & El-Sibai, M. Signaling networks of Rho GTPases in cell motility. Cell. Signal. 25, 1955-1961 (2013
7. Hall, A. Rho family GTPases. Biochem. Soc. Trans. 40, 1378-1382 (2012
8. Longenecker, K. et al. Structure of a constitutively activated RhoA mutant (Q63L) at 1.55 Å resolution. Acta Crystallogr. D Biol. Crystallogr. 59, 876-880 (2003
9. Mayer, T., Meyer, M., Janning, A., Schiedel, A.C. & Barnekow, A. A mutant form of the rho protein can restore stress fibers and adhesion plaques in v-src transformed fibroblasts. Oncogene 18, 2117-2128 (1999
10. Zhang, S. et al. Rho family GTPases regulate p38 mitogen-Activated protein kinase through the downstream mediator Pak1. J. Biol. Chem. 270, 23934-23936 (1995
11. Ghosh, P.M. et al. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line. Oncogene 18, 4120-4130 (1999
12. Pan, Z.K. et al. Role of the Rho GTPase in bradykinin-stimulated nuclear factor-?B activation and IL-1β gene expression in cultured human epithelial cells. J. Immunol. 160, 3038-3045 (1998
13. Reid, T. et al. Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain. J. Biol. Chem. 271, 13556-13560 (1996
14. García-Mata, R. et al. Analysis of activated GAPs and GEFs in cell lysates. Methods Enzymol. 406, 425-437 (2006
15. Couronné, L., Bastard, C. & Bernard, O.A. TET2 and DNMT3A mutations in human T-cell lymphoma. N. Engl. J. Med. 366, 95-96 (2012
16. Quivoron, C. et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20, 25-38 (2011
17. Cairns, R.A. et al. IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood 119, 1901-1903 (2012
18. Palacios, E.H. & Weiss, A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 23, 7990-8000 (2004
19. McCormack, P.L. & Keam, S.J. Dasatinib: A review of its use in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia. Drugs 71, 1771-1795 (2011
20. Harr, M.W. et al. Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia. Cell Death Differ. 17, 1381-1391 (2010
21. Widmann, C., Gerwins, P., Johnson, N.L., Jarpe, M.B. & Johnson, G.L. MEK kinase 1, a substrate for DEVD-directed caspases, is involved in genotoxin-induced apoptosis. Mol. Cell. Biol. 18, 2416-2429 (1998
22. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595 (2010
23. Langmead, B. & Salzberg, S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359 (2012
24. Schmitz, R. et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 490, 116-120 (2012
25. Maher, C.A. et al. Chimeric transcript discovery by paired-end transcriptome sequencing. Proc. Natl. Acad. Sci. USA 106, 12353-12358 (2009
26. McPherson, A. et al. deFuse: An algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput. Biol. 7, e1001138 (2011
27. Pettersen, E.F. et al. UCSF Chimera-A visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612 (2004
28. Altschul, S.F. et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25, 3389-3402 (1997
29. Roy, A., Kucukural, A. & Zhang, Y. I-TASSER: A unified platform for automated protein structure and function prediction. Nat. Protoc. 5, 725-738 (2010
30. Worth, C.L., Preissner, R. & Blundell, T.L. SDM-A server for predicting effects of mutations on protein stability and malfunction. Nucleic Acids Res. 39, W215-W222 (2011
31. Subauste, M.C. et al. Rho family proteins modulate rapid apoptosis induced by cytotoxic T lymphocytes and Fas. J. Biol. Chem. 275, 9725-9733 (2000
32. Mariotti, A. et al. EGF-R signaling through Fyn kinase disrupts the function of integrin a6β4 at hemidesmosomes: Role in epithelial cell migration and carcinoma invasion. J. Cell Biol. 155, 447-458 (2001
33. Kamanova, J. et al. Adenylate cyclase toxin subverts phagocyte function by RhoA inhibition and unproductive ruffling. J. Immunol. 181, 5587-5597 (2008
34. Pallotta, M.T. et al. Indoleamine 2,3-dioxygenase is a signaling protein in long-Term tolerance by dendritic cells. Nat. Immunol. 12, 870-878 (2011
35. Schenk, S. et al. Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction. J. Clin. Invest. 121, 4281-4288 (2011
36. Wang, Q. et al. Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells. J. Biol. Chem. 279, 28831-28834 (2004.